{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:10:15Z","timestamp":1794967815716,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:00:00Z","timestamp":1311724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/npp.2011.132","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T10:10:04Z","timestamp":1311761404000},"page":"2452-2459","source":"Crossref","is-referenced-by-count":824,"title":["The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis"],"prefix":"10.1038","volume":"36","author":[{"given":"Jonas","family":"Hannestad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"DellaGioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"key":"BFnpp2011132_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hup.717","volume":"20","author":"AD Basterzi","year":"2005","unstructured":"Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K et al (2005). IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 20: 473\u2013476.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2011132_CR2","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1073\/pnas.0438019100","volume":"100","author":"A Bierhaus","year":"2003","unstructured":"Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D et al (2003). A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 100: 1920\u20131925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011132_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jad.2009.02.017","volume":"119","author":"L Capuron","year":"2009","unstructured":"Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH (2009). Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord 119: 181\u2013185.","journal-title":"J Affect Disord"},{"key":"BFnpp2011132_CR4","doi-asserted-by":"publisher","first-page":"573594","DOI":"10.1155\/2010\/573594","volume":"2010","author":"YC Chen","year":"2010","unstructured":"Chen YC, Lin WW, Chen YJ, Mao WC, Hung YJ (2010). Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators Inflamm 2010: 573594.","journal-title":"Mediators Inflamm"},{"key":"BFnpp2011132_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neubiorev.2009.07.014","volume":"34","author":"N DellaGioia","year":"2010","unstructured":"DellaGioia N, Hannestad J (2010). A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 34: 130\u2013143.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2011132_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/01.PSY.0000097338.75454.29","volume":"66","author":"SS Dickerson","year":"2004","unstructured":"Dickerson SS, Kemeny ME, Aziz N, Kim KH, Fahey JL (2004). Immunological effects of induced shame and guilt. Psychosom Med 66: 124\u2013131.","journal-title":"Psychosom Med"},{"key":"BFnpp2011132_CR7","first-page":"18","volume":"13","author":"LV Doering","year":"2007","unstructured":"Doering LV, Cross R, Vredevoe D, Martinez-Maza O, Cowan MJ (2007). Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Altern Ther Health Med 13: 18\u201321.","journal-title":"Altern Ther Health Med"},{"key":"BFnpp2011132_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011132_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.neuroimage.2009.04.040","volume":"47","author":"NI Eisenberger","year":"2009","unstructured":"Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2009). An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47: 881\u2013890.","journal-title":"Neuroimage"},{"key":"BFnpp2011132_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","volume":"32","author":"T Eller","year":"2008","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2008). Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32: 445\u2013450.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2011132_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0269881108091077","volume":"23","author":"T Eller","year":"2009","unstructured":"Eller T, Vasar V, Shlik J, Maron E (2009). Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. J Psychopharmacol 23: 854\u2013858.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2011132_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/NDT.S16382","volume":"7","author":"M Fornaro","year":"2011","unstructured":"Fornaro M, Martino M, Battaglia F, Colicchio S, Perugi G (2011). Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60\u2009mg\/day: a preliminary observation. Neuropsychiatr Dis Treat 7: 51\u201356.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFnpp2011132_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02900219","volume":"247","author":"UH Frommberger","year":"1997","unstructured":"Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M (1997). Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247: 228\u2013233.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp2011132_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00421-006-0150-8","volume":"97","author":"Y Gundersen","year":"2006","unstructured":"Gundersen Y, Opstad PK, Reistad T, Thrane I, Vaagenes P (2006). Seven days\u2019 around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes. Eur J Appl Physiol 97: 151\u2013157.","journal-title":"Eur J Appl Physiol"},{"key":"BFnpp2011132_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2010.10.013","volume":"25","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Ortiz N, Pittman B, Bhagwagar Z (2011). Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun 25: 256\u2013259.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2011132_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.euroneuro.2008.08.001","volume":"18","author":"ME Hernandez","year":"2008","unstructured":"Hernandez ME, Mendieta D, Martinez-Fong D, Loria F, Moreno J, Estrada I et al (2008). Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. Eur Neuropsychopharmacol 18: 917\u2013924.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2011132_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","volume":"60","author":"H Himmerich","year":"2006","unstructured":"Himmerich H, Binder EB, Kunzel HE, Schuld A, Lucae S, Uhr M et al (2006). Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 60: 882\u2013888.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011132_CR18","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jpsychires.2010.03.005","volume":"44","author":"H Himmerich","year":"2010","unstructured":"Himmerich H, Milenovic S, Fulda S, Plumakers B, Sheldrick AJ, Michel TM et al (2010). Regulatory T cells increased while IL-1beta decreased during antidepressant therapy. J Psychiatr Res 44: 1052\u20131057.","journal-title":"J Psychiatr Res"},{"key":"BFnpp2011132_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0893-133X(00)00089-0","volume":"23","author":"D Hinze-Selch","year":"2000","unstructured":"Hinze-Selch D, Schuld A, Kraus T, Kuhn M, Uhr M, Haack M et al (2000). Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23: 13\u201319.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011132_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171\u2013186.","journal-title":"Psychosom Med"},{"key":"BFnpp2011132_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","volume":"178","author":"S Jazayeri","year":"2010","unstructured":"Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H et al (2010). Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res 178: 112\u2013115.","journal-title":"Psychiatry Res"},{"key":"BFnpp2011132_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000054867","volume":"43","author":"A Kagaya","year":"2001","unstructured":"Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S et al (2001). Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 43: 59\u201362.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2011132_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/1097-4679(199311)49:6<777::AID-JCLP2270490605>3.0.CO;2-2","volume":"49","author":"WH Keppel","year":"1993","unstructured":"Keppel WH, Regan DH, Heffeneider SH, McCoy S, Ramsey F (1993). Effects of behavioral stimuli on plasma interleukin-1 activity in humans at rest. J Clin Psychol 49: 777\u2013789.","journal-title":"J Clin Psychol"},{"key":"BFnpp2011132_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-2002-36390","volume":"35","author":"T Kraus","year":"2002","unstructured":"Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmacher T (2002). Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 35: 220\u2013225.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp2011132_CR25","first-page":"237","volume":"52","author":"M Kubera","year":"2000","unstructured":"Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G et al (2000). Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52: 237\u2013241.","journal-title":"Pol J Pharmacol"},{"key":"BFnpp2011132_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3346\/jkms.2004.19.3.384","volume":"19","author":"SK Lee","year":"2004","unstructured":"Lee SK, Lee HS, Lee TB, Kim DH, Koo JR, Kim YK et al (2004). The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients. J Korean Med Sci 19: 384\u2013389.","journal-title":"J Korean Med Sci"},{"key":"BFnpp2011132_CR27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.4088\/JCP.v67n1114","volume":"67","author":"R Leo","year":"2006","unstructured":"Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G et al (2006). Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 67: 1760\u20131766.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2011132_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1006\/cyto.1997.0238","volume":"9","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9: 853\u2013858.","journal-title":"Cytokine"},{"key":"BFnpp2011132_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R et al (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34: 301\u2013309.","journal-title":"J Affect Disord"},{"key":"BFnpp2011132_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001). Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11: 203\u2013208.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2011132_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011132_CR32","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B et al (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11: 680\u2013684.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2011132_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","volume":"163","author":"TW Pace","year":"2006","unstructured":"Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH et al (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163: 1630\u20131633.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2011132_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","volume":"19","author":"VA Pavlov","year":"2005","unstructured":"Pavlov VA, Tracey KJ (2005). The cholinergic anti-inflammatory pathway. Brain Behav Immun 19: 493\u2013499.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2011132_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/15622970802573246","volume":"10","author":"JE Piletz","year":"2009","unstructured":"Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H et al (2009). Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry 10: 313\u2013323.","journal-title":"World J Biol Psychiatry"},{"key":"BFnpp2011132_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/clpt.2009.121","volume":"86","author":"C Pizzi","year":"2009","unstructured":"Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, Costa GM (2009). Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther 86: 527\u2013532.","journal-title":"Clin Pharmacol Ther"},{"key":"BFnpp2011132_CR37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","volume":"67","author":"CL Raison","year":"2010","unstructured":"Raison CL, Lowry CA, Rook GA (2010). Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 67: 1211\u20131224.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2011132_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445\u2013452.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2011132_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1465-9921-8-35","volume":"8","author":"C Roumestan","year":"2007","unstructured":"Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C et al (2007). Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 8: 35.","journal-title":"Respir Res"},{"key":"BFnpp2011132_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0014-2999(03)01721-7","volume":"469","author":"Z Selmeczy","year":"2003","unstructured":"Selmeczy Z, Szelenyi J, Vizi ES (2003). Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance. Eur J Pharmacol 469: 175\u2013181.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2011132_CR41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2009.09.019","volume":"31","author":"I Shaked","year":"2009","unstructured":"Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A et al (2009). MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31: 965\u2013973.","journal-title":"Immunity"},{"key":"BFnpp2011132_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","volume":"762","author":"A Sluzewska","year":"1995","unstructured":"Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762: 474\u2013476.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2011132_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0029-1202263","volume":"42","author":"C Song","year":"2009","unstructured":"Song C, Halbreich U, Han C, Leonard BE, Luo H (2009). Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 42: 182\u2013188.","journal-title":"Pharmacopsychiatry"},{"key":"BFnpp2011132_CR44","doi-asserted-by":"publisher","first-page":"76396","DOI":"10.1155\/2007\/76396","volume":"2007","author":"L Sutcigil","year":"2007","unstructured":"Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O et al (2007). Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007: 76396.","journal-title":"Clin Dev Immunol"},{"key":"BFnpp2011132_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.bbi.2010.07.247","volume":"24","author":"JF Thayer","year":"2010","unstructured":"Thayer JF, Sternberg EM (2010). Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav Immun 24: 1223\u20131228.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2011132_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biopsych.2004.03.009","volume":"56","author":"P Tucker","year":"2004","unstructured":"Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP et al (2004). Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry 56: 121\u2013128.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011132_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","volume":"170","author":"C Tuglu","year":"2003","unstructured":"Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003). Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170: 429\u2013433.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2011132_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A et al (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367: 29\u201335.","journal-title":"Lancet"},{"key":"BFnpp2011132_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00421-009-1341-x","volume":"109","author":"CS Weber","year":"2010","unstructured":"Weber CS, Thayer JF, Rudat M, Wirtz PH, Zimmermann-Viehoff F, Thomas A et al (2010). Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers. Eur J Appl Physiol 109: 201\u2013211.","journal-title":"Eur J Appl Physiol"},{"key":"BFnpp2011132_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbi.2004.10.003","volume":"19","author":"CE Wright","year":"2005","unstructured":"Wright CE, Strike PC, Brydon L, Steptoe A (2005). Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun 19: 345\u2013350.","journal-title":"Brain Behav Immun"},{"key":"BFnpp2011132_CR51","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","volume":"185","author":"Y Yan","year":"2010","unstructured":"Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H et al (2010). IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185: 5953\u20135961.","journal-title":"J Immunol"},{"key":"BFnpp2011132_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0893-133X(00)00226-8","volume":"24","author":"R Yirmiya","year":"2001","unstructured":"Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M et al (2001). Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24: 531\u2013544.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011132_CR53","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","volume":"33","author":"R Yoshimura","year":"2009","unstructured":"Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J (2009). Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 722\u2013726.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2011132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:24:25Z","timestamp":1684441465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2011132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFnpp2011132"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.132","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,27]]}}}